Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes

[1]  O. Combarros,et al.  Gene–gene interaction between heme oxygenase-1 and liver X receptor-β and Alzheimer's disease risk , 2010, Neurobiology of Aging.

[2]  C. Dethlefsen,et al.  Associations between COX-2 polymorphisms, blood cholesterol and risk of acute coronary syndrome. , 2010, Atherosclerosis.

[3]  C. Boland,et al.  Recent insights into the pathogenesis of colorectal cancer , 2010, Current opinion in gastroenterology.

[4]  Vibeke Andersen,et al.  Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study , 2009, BMC Cancer.

[5]  Ikumi Chisaki,et al.  Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver. , 2009, Biochimica et biophysica acta.

[6]  P. Ascenzi,et al.  Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. , 2009, Molecular aspects of medicine.

[7]  Mark Woodward,et al.  The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence , 2009, International journal of cancer.

[8]  E. Rimm,et al.  The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. , 2009, European heart journal.

[9]  C. Dethlefsen,et al.  PPARγ Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes , 2009, BMC Medical Genetics.

[10]  W. Wu,et al.  Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  Edward Giovannucci,et al.  Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta‐analysis , 2009, International journal of cancer.

[12]  P. Elwood,et al.  Aspirin, salicylates, and cancer , 2009, The Lancet.

[13]  U. Vogel,et al.  The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT , 2009, Bone Marrow Transplantation.

[14]  U. Vogel,et al.  The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study , 2009, BMC Medical Genetics.

[15]  B. Aggarwal,et al.  Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe , 2009, Clinical Cancer Research.

[16]  U. Vogel,et al.  Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study , 2009, Cancer Causes & Control.

[17]  J. K. Kundu,et al.  Inflammation: gearing the journey to cancer. , 2008, Mutation research.

[18]  Joe Palandra,et al.  Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe , 2008, Pharmacogenetics and genomics.

[19]  Y. Wan,et al.  Nuclear Receptors and Inflammatory Diseases , 2008, Experimental biology and medicine.

[20]  U. Vogel,et al.  Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. , 2008, Mutation research.

[21]  U. Vogel,et al.  A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a danish prospective case-cohort study , 2008, BMC Cancer.

[22]  U. Vogel,et al.  Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. , 2008, Lung cancer.

[23]  U. Vogel,et al.  Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. , 2007, Mutation research.

[24]  M. Neuenhahn,et al.  NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ , 2007, Cell.

[25]  A. Tjønneland,et al.  Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: A population-based prospective cohort study of 57,053 men and women in Denmark , 2007, Scandinavian journal of public health.

[26]  U. Vogel,et al.  XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. , 2007, Mutation research.

[27]  P. Rothwell,et al.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.

[28]  U. Vogel,et al.  GPX1 Pro198Leu polymorphism, interactions with smoking and alcohol consumption, and risk for lung cancer. , 2007, Cancer letters.

[29]  R. DuBois,et al.  Inflammatory Mediators and Nuclear Receptor Signaling in Colorectal Cancer , 2007, Cell cycle.

[30]  A. Lindblom,et al.  Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations , 2007, Scandinavian journal of gastroenterology.

[31]  G. Courtois,et al.  NF-κB and inflammation in genetic disease , 2006 .

[32]  L. Komuves,et al.  Non-viral delivery of nuclear factor-κB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis , 2006, Gut.

[33]  U. Vogel,et al.  Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer. , 2006, Free radical research.

[34]  S. Fiorucci,et al.  PPARs and other nuclear receptors in inflammation. , 2006, Current opinion in pharmacology.

[35]  B. Blumberg,et al.  Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. , 2006, The Journal of clinical investigation.

[36]  P. Oates,et al.  Heme in intestinal epithelial cell turnover, differentiation, detoxification, inflammation, carcinogenesis, absorption and motility. , 2006, World journal of gastroenterology.

[37]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[38]  C. O'Morain,et al.  The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. , 2006, Gastroenterology.

[39]  T. A. Richardson,et al.  Regulation of drug-metabolizing enzymes and transporters in inflammation. , 2006, Annual review of pharmacology and toxicology.

[40]  U. Vogel,et al.  Interactions between the OGG1 Ser326Cys polymorphism and intake of fruit and vegetables in relation to lung cancer , 2006 .

[41]  U. Vogel,et al.  GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. , 2005, Cancer letters.

[42]  L. Stark,et al.  Evidence for colorectal cancer cell specificity of aspirin effects on NFκB signalling and apoptosis , 2004, British Journal of Cancer.

[43]  K. Scotto.  Transcriptional regulation of ABC drug transporters , 2003, Oncogene.

[44]  J. Hudson,et al.  The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. , 2001, Pharmacogenetics.

[45]  L. Stark,et al.  Aspirin‐induced activation of the NF‐κB signaling pathway: a novel mechanism for aspirin‐mediated apoptosis in colon cancer cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  W E Barlow,et al.  Analysis of case-cohort designs. , 1999, Journal of clinical epidemiology.

[47]  J. Piette,et al.  Involvement of different transduction pathways in NF-kappa B activation by several inducers. , 1997, Free radical research.

[48]  L. Kinlen.  Mortality from smoking in developed countries 1950-2000 , 1996, British Journal of Cancer.

[49]  W. Barlow,et al.  Robust variance estimation for the case-cohort design. , 1994, Biometrics.

[50]  M. Tsechkovski,et al.  WHO Regional Office for Europe , 1993, The Lancet.

[51]  A. Tjønneland,et al.  Influence of individually estimated portion size data on the validity of a semiquantitative food frequency questionnaire. , 1992, International journal of epidemiology.

[52]  A. Tjønneland,et al.  Validation of a semiquantitative food frequency questionnaire developed in Denmark. , 1991, International journal of epidemiology.

[53]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[54]  N. Asp,et al.  Determination of total dietary fiber in foods and food products: collaborative study. , 1985, Journal - Association of Official Analytical Chemists.

[55]  E. Rimm,et al.  S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in three prospective cohort studies , 2011 .

[56]  S. Teng,et al.  Regulation of transporters by nuclear hormone receptors: implications during inflammation. , 2008, Molecular pharmaceutics.

[57]  P. Villiger,et al.  The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. , 2007, Rheumatology.

[58]  M. Neuenhahn,et al.  NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. , 2007, Cell.

[59]  P. Villiger,et al.  The −308 tumour necrosis factor-α gene polymorphism predicts therapeutic response to TNFα-blockers in rheumatoid arthritis and spondyloarthritis patients , 2007 .

[60]  M. Karin.  Nuclear factor-kappaB in cancer development and progression. , 2006, Nature.

[61]  G. Courtois,et al.  NF-kappaB and inflammation in genetic disease. , 2006, Biochemical pharmacology.

[62]  Judy H. Cho,et al.  Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. , 2004, Human molecular genetics.

[63]  D. Birnbaum,et al.  BMC Cancer , 2003 .

[64]  L. Stark,et al.  Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.